All Stories

  1. ISG15 overexpression compensates the defect of Crimean-Congo hemorrhagic fever virus polymerase bearing a protease-inactive ovarian tumor domain
  2. NSs Protein of Sandfly Fever Sicilian Phlebovirus Counteracts Interferon (IFN) Induction by Masking the DNA-Binding Domain of IFN Regulatory Factor 3
  3. Immunization with DNA Plasmids Coding for Crimean-Congo Hemorrhagic Fever Virus Capsid and Envelope Proteins and/or Virus-Like Particles Induces Protection and Survival in Challenged Mice
  4. Transcription and replication mechanisms of Bunyaviridae and Arenaviridae L proteins
  5. Standing on three legs: antiviral activities of RIG-I against influenza viruses
  6. Homage to Richard M. Elliott
  7. To Conquer the Host, Influenza Virus Is Packing It In: Interferon-Antagonistic Strategies beyond NS1
  8. Phleboviruses and the Type I Interferon Response
  9. Evidence for widespread infection of African bats with Crimean-Congo hemorrhagic fever-like viruses
  10. NSs Virulence Factor of Rift Valley Fever Virus Engages the F-Box Proteins FBXW11 and β-TRCP1 To Degrade the Antiviral Protein Kinase PKR
  11. High-Throughput Screening Using a Whole-Cell Virus Replication Reporter Gene Assay to Identify Inhibitory Compounds against Rift Valley Fever Virus Infection
  12. The catcher in the RIG-I
  13. Meeting report: First International Conference on Crimean-Congo hemorrhagic fever
  14. Orthobunyaviruses and innate immunity induction: alieNSs vs. PredatoRRs
  15. A Virus-Like Particle System Identifies the Endonuclease Domain of Crimean-Congo Hemorrhagic Fever Virus
  16. Influenza Virus Adaptation PB2-627K Modulates Nucleocapsid Inhibition by the Pathogen Sensor RIG-I
  17. SUMO modification of TBK1 at the adaptor-binding C-terminal coiled-coil domain contributes to its antiviral activity
  18. RIG-I-like receptors and negative-strand RNA viruses: RLRly bird catches some worms
  19. Segmented negative-strand RNA viruses and RIG-I: divide (your genome) and rule
  20. Monitoring Activation of the Antiviral Pattern Recognition Receptors RIG-I And PKR By Limited Protease Digestion and Native PAGE
  21. Bunyaviruses and Innate Immunity
  22. Structural insights into RNA encapsidation and helical assembly of the Toscana virus nucleoprotein
  23. Virulence Factor NSs of Rift Valley Fever Virus Recruits the F-Box Protein FBXO3 To Degrade Subunit p62 of General Transcription Factor TFIIH
  24. Viperin is an iron-sulfur protein that inhibits genome synthesis of tick-borne encephalitis virus via radical SAM domain activity
  25. Middle East Respiratory Syndrome Coronavirus Accessory Protein 4a Is a Type I Interferon Antagonist
  26. IFIT2 Is an Effector Protein of Type I IFN-Mediated Amplification of Lipopolysaccharide (LPS)-Induced TNF-  Secretion and LPS-Induced Endotoxin Shock
  27. Systems To Establish Bunyavirus Genome Replication in the Absence of Transcription
  28. Crystal structure of tetramer of La Crosse virus nucleoprotein in complex with ssRNA
  29. Structural basis for encapsidation of genomic RNA by La Crosse Orthobunyavirus nucleoprotein
  30. Incoming RNA Virus Nucleocapsids Containing a 5′-Triphosphorylated Genome Activate RIG-I and Antiviral Signaling
  31. Human Cell Tropism and Innate Immune System Interactions of Human Respiratory Coronavirus EMC Compared to Those of Severe Acute Respiratory Syndrome Coronavirus
  32. Structure of Crimean-Congo Hemorrhagic Fever Virus Nucleoprotein: Superhelical Homo-Oligomers and the Role of Caspase-3 Cleavage
  33. Viral immune modulators perturb the human molecular network by common and unique strategies
  34. Regulatory, biosafety and safety challenges for novel cells as substrates for human vaccines
  35. Reverse Genetics of SARS-Related Coronavirus Using Vaccinia Virus-Based Recombination
  36. Induction of DNA Damage Signaling upon Rift Valley Fever Virus Infection Results in Cell Cycle Arrest and Increased Viral Replication
  37. The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors
  38. IFIT1 is an antiviral protein that recognizes 5′-triphosphate RNA
  39. Hiding from intracellular pattern recognition receptors, a passive strategy of flavivirus immune evasion
  40. The Crimean Congo Hemorrhagic Fever European Consortium: Modern Approaches to Diagnostics, Epidemiology, Prevention, Therapy and Preparedness
  41. Completion of Hepatitis C Virus Replication Cycle in Heterokaryons Excludes Dominant Restrictions in Human Non-liver and Mouse Liver Cell Lines
  42. The ADP-ribose-1''-monophosphatase domains of severe acute respiratory syndrome coronavirus and human coronavirus 229E mediate resistance to antiviral interferon responses
  43. Old World hantaviruses do not produce detectable amounts of dsRNA in infected cells and the 5' termini of their genomic RNAs are monophosphorylated
  44. Interferon Antagonist NSs of La Crosse Virus Triggers a DNA Damage Response-like Degradation of Transcribing RNA Polymerase II
  45. N-terminal endonuclease domain of La Crosse virus L-protein
  46. N-terminal endonuclease domain of La Crosse virus L-protein
  47. Toscana virus induces interferon although its NSs protein reveals antagonistic activity
  48. Bunyaviridae RNA Polymerases (L-Protein) Have an N-Terminal, Influenza-Like Endonuclease Domain, Essential for Viral Cap-Dependent Transcription
  49. Extracellular 2′-5′ Oligoadenylate Synthetase Stimulates RNase L-Independent Antiviral Activity: a Novel Mechanism of Virus-Induced Innate Immunity
  50. La Crosse virus (LACV) Gc fusion peptide mutants have impaired growth and fusion phenotypes, but remain neurotoxic
  51. Virus-Like Particles Expressing the Nucleocapsid Gene as an Efficient Vaccine Against Rift Valley Fever Virus
  52. Interferon interplay helps tissue cells to cope with SARS-Coronavirus infection
  53. Tick-Borne Encephalitis Virus Delays Interferon Induction and Hides Its Double-Stranded RNA in Intracellular Membrane Vesicles
  54. Molecular Biology of Rift Valley Fever Virus~!2009-11-04~!2009-11-25~!2010-04-22~!
  55. Species-independent bioassay for sensitive quantification of antiviral type I interferons
  56. Bunyaviruses and the Type I Interferon System
  57. Differential Downregulation of ACE2 by the Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus and Human Coronavirus NL63
  58. Thogoto virus ML protein is a potent inhibitor of the interferon regulatory factor-7 transcription factor
  59. Interferon priming enables cells to partially overturn the SARS coronavirus-induced block in innate immune activation
  60. Efficient production of Rift Valley fever virus-like particles: The antiviral protein MxA can inhibit primary transcription of bunyaviruses
  61. Vaccination with virus-like particles protects mice from lethal infection of Rift Valley Fever Virus
  62. NSs Protein of Rift Valley Fever Virus Induces the Specific Degradation of the Double-Stranded RNA-Dependent Protein Kinase
  63. Electron Cryo-Microscopy and Single-Particle Averaging of Rift Valley Fever Virus: Evidence for GN-GC Glycoprotein Heterodimers
  64. Severe Acute Respiratory Syndrome Coronavirus Triggers Apoptosis via Protein Kinase R but Is Resistant to Its Antiviral Activity
  65. Interferon and cytokine responses to Crimean Congo hemorrhagic fever virus; an emerging and neglected viral zonoosis
  66. The Interferon Antagonist ML Protein of Thogoto Virus Targets General Transcription Factor IIB
  67. T7 RNA polymerase-dependent and -independent systems for cDNA-based rescue of Rift Valley fever virus
  68. Processing of Genome 5′ Termini as a Strategy of Negative-Strand RNA Viruses to Avoid RIG-I-Dependent Interferon Induction
  69. Interferon and cytokine responses to SARS-coronavirus infection
  70. Crimean-Congo hemorrhagic fever virus delays activation of the innate immune response
  71. Innate Immunity: Introduction
  72. Interferon, Mx, and viral countermeasures
  73. Viral suppression of the interferon system
  74. Interferon-induced Mx proteins in antiviral host defense
  75. The intracellular sites of early replication and budding of SARS-coronavirus
  76. La Crosse Bunyavirus Nonstructural Protein NSs Serves To Suppress the Type I Interferon System of Mammalian Hosts
  77. Tula and Puumala hantavirus NSs ORFs are functional and the products inhibit activation of the interferon-beta promoter
  78. Interaction of hepatitis C virus with the type I interferon system
  79. Coronavirus Non-Structural Protein 1 Is a Major Pathogenicity Factor: Implications for the Rational Design of Coronavirus Vaccines
  80. RIG-I-Mediated Antiviral Responses to Single-Stranded RNA Bearing 5'-Phosphates
  81. Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon
  82. Interaction of severe acute respiratory syndrome-associated coronavirus with dendritic cells
  83. Neurons produce type I interferon during viral encephalitis
  84. Double-Stranded RNA Is Produced by Positive-Strand RNA Viruses and DNA Viruses but Not in Detectable Amounts by Negative-Strand RNA Viruses
  85. Global Suppression of the Host Antiviral Response by Ebola- and Marburgviruses: Increased Antagonism of the Type I Interferon Response Is Associated with Enhanced Virulence
  86. A target on the move: Innate and adaptive immune escape strategies of hepatitis C virus
  87. The interferon response circuit: Induction and suppression by pathogenic viruses
  88. Induction of Interferon Synthesis by the PKR-Inhibitory VA RNAs of Adenoviruses
  89. Activation of Innate Defense against a Paramyxovirus Is Mediated by RIG-I and TLR7 and TLR8 in a Cell-Type-Specific Manner
  90. Efficient cDNA-Based Rescue of La Crosse Bunyaviruses Expressing or Lacking the Nonstructural Protein NSs
  91. Inhibition of Beta Interferon Induction by Severe Acute Respiratory Syndrome Coronavirus Suggests a Two-Step Model for Activation of Interferon Regulatory Factor 3
  92. Thogoto virus ML protein suppresses IRF3 function
  93. Inverse Interference: How Viruses Fight the Interferon System
  94. NSs Protein of Rift Valley Fever Virus Blocks Interferon Production by Inhibiting Host Gene Transcription
  95. The antiviral effect of interferon-beta against SARS-Coronavirus is not mediated by MxA protein
  96. Inhibition of RNA Polymerase II Phosphorylation by a Viral Interferon Antagonist
  97. Inhibition of Dugbe nairovirus replication by human MxA protein
  98. Bunyamwera Virus Nonstructural Protein NSs Counteracts Interferon Regulatory Factor 3-Mediated Induction of Early Cell Death
  99. Activation of PKR by Bunyamwera Virus Is Independent of the Viral Interferon Antagonist NSs
  100. Functional L polymerase of La Crosse virus allows in vivo reconstitution of recombinant nucleocapsids
  101. Viral Evasion of the Interferon System: Old Viruses, New Tricks
  102. Novel Gene Product of Thogoto Virus Segment 6 Codes for an Interferon Antagonist
  103. Antigenic drift, antigenic shift and interferon antagonists: how bunyaviruses counteract the immune system
  104. Bunyamwera Bunyavirus Nonstructural Protein NSs Counteracts the Induction of Alpha/Beta Interferon
  105. The Bunyamwera Virus Nonstructural Protein NSs Inhibits Viral RNA Synthesis in a Minireplicon System
  106. Bunyamwera bunyavirus nonstructural protein NSs is a nonessential gene product that contributes to viral pathogenesis
  107. Formation of virus-like particles from cloned cDNAs of Thogoto virus
  108. Thogoto Virus Matrix Protein Is Encoded by a Spliced mRNA
  109. MxA GTPase Blocks Reporter Gene Expression of Reconstituted Thogoto Virus Ribonucleoprotein Complexes
  110. PB2 polymerase subunit of Thogoto virus (Orthomyxoviridae family)
  111. The Polypeptides pucD and pucE Stabilize the LHII (B800–850) Light-Harvesting Complex of Rhodobacter Capsulatus 37B4 and Support an Effective Assembly
  112. In vivo reconstitution of active Thogoto virus polymerase: assays for the compatibility with other orthomyxovirus core proteins and template RNAs
  113. A Classical Bipartite Nuclear Localization Signal on Thogoto and Influenza A Virus Nucleoproteins
  114. Mx1 sensitivity: Batken virus is an orthomyxovirus closely related to Dhori virus.
  115. The fourth genus in the Orthomyxoviridae: sequence analyses of two Thogoto virus polymerase proteins and comparison with influenza viruses
  116. Conserved vRNA end sequences of Thogoto-orthomyxovirus suggest a new panhandle structure
  117. Pathogenic Viruses: Smart Manipulators of the Interferon System